The most recently added documents are listed below. To narrow down the results into the key area you are interested in, select the relevant term and press search. You can narrow the results further by selecting more terms. Untick a selected box to remove that filter or click reset to start over.
This study evaluated a cohort of children ages 1-36 months in communities randomized to biannual treatment of children with azithromycin or placebo.
This manual is a facilitator’s guide to conduct a workshop to train supervisors for the distribution of Zithromax® as part of a Mass Drug Administration (MDA) programme for trachoma elimination.
Le présent manuel est un guide destiné aux personnes animant des ateliers pour former des superviseurs à la distribution de Zithromax® dans le cadre du programme d’administration massive de médicaments (AMM) en vue de l’élimination du trachome.
While evaluations on the implementation of the SAFE strategy have been done, systematic reviews on the factors that have shaped implementation are lacking. This review sought to identify these factors.
This study tested the hypothesis that an automated algorithm could classify eyelid photographs better than chance.
This toolkit provides step-by-step guidance to NTD program managers and partners on how to engage and work collaboratively with the WASH community to improve delivery of services to underserved population affected by many NTDs.
This study aims to quantify and characterize research activity and treatment availability for NTDs in children in order to inform the prioritization of future research efforts.
Program decision-making for trachoma elimination currently relies on conjunctival clinical signs. Antibody tests may provide additional information on the epidemiology of trachoma, particularly in regions where it is disappearing or elimination targets have been met.
This study explored factors associated with individual MDA participation at the individual, head of household, and household levels in Amhara, Ethiopia.
This study looks at the prevalence of self-reported side effects was assessed among those who self-reported receiving azithromycin 3 weeks following the 2016 trachoma MDA in Amhara, Ethiopia